Sinovac Biotech Ltd
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q4 23 | Q2 24 | Q4 24 | Q2 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -6.3% | +0.0% | +0.0% | -2.8% | -0.5% | -5.6% | -4.3% | -2.8% | -28.7% | +0.0% | -4.7% | |
| – | -7.5% | +0.0% | – | – | +0.5% | -5.8% | -4.5% | -2.5% | -31.9% | +0.0% | -6.2% | |
| – | -37.6% | +0.0% | – | – | -22.7% | -15.6% | -68.7% | -45.5% | +167.3% | +0.0% | -34.0% | |
| – | -4.5% | +0.0% | – | – | +1.4% | -5.8% | – | – | – | – | – | |
| – | -37.1% | +0.0% | – | – | -9.9% | -10.2% | -25.7% | +2.0% | -6.7% | +9.3% | -15.1% | |
| – | -32.3% | +0.0% | – | – | -23.5% | +9.8% | -36.9% | +12.6% | -13.6% | +0.0% | +13.0% | |
| – | – | – | – | – | – | – | – | -57.1% | +6.8% | +0.0% | +3.0% | |
| – | +71.9% | +0.0% | – | – | -0.3% | -4.5% | +160.2% | -25.9% | +2.6% | +0.0% | +1.6% | |
| – | +44.2% | +0.0% | – | – | +9.9% | -15.0% | +47.0% | +176.1% | -62.0% | +0.0% | -22.0% | |
| – | +93.3% | +0.0% | – | – | -3.5% | -14.8% | +48.4% | +244.5% | -69.2% | +0.0% | -29.2% | |
| – | +33.5% | +0.0% | – | – | -61.2% | +122.0% | – | – | – | – | – | |
| – | -94.1% | +4,469.6% | – | – | -97.9% | +3,610.5% | -98.1% | +4,717.4% | -97.3% | +0.0% | +1,442.1% | |
| – | – | – | – | – | +1,518.1% | -26.7% | +25.7% | +42.2% | +13.9% | – | – | |
| – | -5.8% | +0.0% | – | – | +0.5% | -0.7% | -4.5% | -47.1% | +1.6% | +0.0% | +1.5% | |
| – | -5.2% | +0.0% | – | – | -1.7% | -0.2% | -3.8% | -58.2% | -1.5% | +0.0% | -2.1% | |
| – | -12.8% | +0.0% | +14.7% | +0.0% | -12.8% | -27.9% | +0.0% | +0.0% | +0.0% | – | – |
Data as of: September 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.